The pharmaceutical landscape is seeing a change with the introduction of GLP-1 transdermal systems . These innovative formulations offer a potential approach to delivering glucagon-like peptide-1 drugs for https://honeygigv877334.estate-blog.com/39795066/glp-1-patches-a-novel-way-to-treat-diabetes